Claim 30% Off TipRanks
- Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions
- Discover top-performing stock ideas and upgrade to a portfolio of market leaders with Smart Investor Picks
Syngene International Ltd. ( (IN:SYNGENE) ) has shared an announcement.
Syngene International Limited has announced the availability of the transcript for its Q1 FY2026 earnings call, which took place on July 24, 2025. The transcript is accessible on the company’s website, providing stakeholders with insights into the company’s financial performance and strategic direction for the quarter.
More about Syngene International Ltd.
Syngene International Limited operates in the biotechnology industry, providing services in drug discovery, development, and manufacturing. The company focuses on delivering integrated scientific solutions to the pharmaceutical, biotechnology, and agrochemical sectors.
Average Trading Volume: 28,975
Technical Sentiment Signal: Hold
Current Market Cap: 278.1B INR
See more data about SYNGENE stock on TipRanks’ Stock Analysis page.